BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, Choi BI. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 2006;239:113-121. [PMID: 16467211 DOI: 10.1148/radiol.2383050419] [Cited by in Crossref: 139] [Cited by in F6Publishing: 105] [Article Influence: 9.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Mao Y, Chen J, Qiu Y, Wang Z, He J. Preoperative Computed Tomography Features of Intrahepatic Cholangiocarcinoma for Predicting Lymph Node Metastasis and Overall Survival: . Journal of Computer Assisted Tomography 2019;43:729-35. [DOI: 10.1097/rct.0000000000000922] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Parodi A, Fisher D, Giovannini M, Baron T, Conio M. Endoscopic management of hilar cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2012;9:105-12. [DOI: 10.1038/nrgastro.2011.271] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
3 Ryoo I, Lee JM, Chung YE, Park HS, Kim SH, Han JK, Choi BI. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer. Invest Radiol. 2010;45:217-224. [PMID: 20195160 DOI: 10.1097/rli.0b013e3181d2eeb1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
4 Sainani NI, Catalano OA, Holalkere NS, Zhu AX, Hahn PF, Sahani DV. Cholangiocarcinoma: current and novel imaging techniques. Radiographics. 2008;28:1263-1287. [PMID: 18794305 DOI: 10.1148/rg.285075183] [Cited by in Crossref: 88] [Cited by in F6Publishing: 56] [Article Influence: 6.8] [Reference Citation Analysis]
5 Wu XP, Ni JM, Zhang ZY, Lu FQ, Li B, Jin HH, Dai T. Preoperative Evaluation of Malignant Perihilar Biliary Obstruction: Negative-Contrast CT Cholangiopancreatography and CT Angiography Versus MRCP and MR Angiography. AJR Am J Roentgenol 2015;205:780-8. [PMID: 26397326 DOI: 10.2214/AJR.14.13983] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Gleeson FC, Rajan E, Levy MJ, Clain JE, Topazian MD, Harewood GC, Papachristou GI, Takahashi N, Rosen CB, Gores GJ. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc. 2008;67:438-443. [PMID: 18061597 DOI: 10.1016/j.gie.2007.07.018] [Cited by in Crossref: 96] [Cited by in F6Publishing: 75] [Article Influence: 6.9] [Reference Citation Analysis]
7 Rauws EA, Kloek JJ, Gouma DJ, Van Gulik TM. Staging of cholangiocarcinoma: the role of endoscopy. HPB (Oxford) 2008;10:110-2. [PMID: 18773066 DOI: 10.1080/13651820801992591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
8 Masselli G, Manfredi R, Vecchioli A, Gualdi G. MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Eur Radiol. 2008;18:2213-2221. [PMID: 18463877 DOI: 10.1007/s00330-008-1004-z] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
9 Chryssou E, Guthrie JA, Ward J, Robinson PJ. Hilar cholangiocarcinoma: MR correlation with surgical and histological findings. Clin Radiol. 2010;65:781-788. [PMID: 20797463 DOI: 10.1016/j.crad.2010.04.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
10 Fowler KJ, Saad NE, Linehan D. Imaging Approach to Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer. Surgical Oncology Clinics of North America 2015;24:19-40. [DOI: 10.1016/j.soc.2014.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
11 Molina V, Sampson J, Ferrer J, Díaz A, Ayuso JR, Sánchez-Cabús S, Fuster J, García-Valdecasas JC. Surgical treatment of perihilar cholangiocarcinoma: early results of en bloc portal vein resection. Langenbecks Arch Surg 2017;402:95-104. [PMID: 28012034 DOI: 10.1007/s00423-016-1542-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
12 Coelen RJS, Gaspersz MP, Labeur TA, van Vugt JLA, van Dieren S, Willemssen FEJA, Nio CY, IJzermans JNM, Klümpen HJ, Groot Koerkamp B, van Gulik TM. Validation of the Mayo Clinic Staging System in Determining Prognoses of Patients With Perihilar Cholangiocarcinoma. Clin Gastroenterol Hepatol 2017;15:1930-1939.e3. [PMID: 28532698 DOI: 10.1016/j.cgh.2017.04.044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ji GW, Zhang YD, Zhang H, Zhu FP, Wang K, Xia YX, Zhang YD, Jiang WJ, Li XC, Wang XH. Biliary Tract Cancer at CT: A Radiomics-based Model to Predict Lymph Node Metastasis and Survival Outcomes. Radiology. 2019;290:90-98. [PMID: 30325283 DOI: 10.1148/radiol.2018181408] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 20.0] [Reference Citation Analysis]
14 Choi BI, Lee JM. Neoplasms of the Gallbladder and Biliary Tract. Textbook of Gastrointestinal Radiology. Elsevier; 2008. pp. 1467-87. [DOI: 10.1016/b978-1-4160-2332-6.50086-5] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
15 Miller G, Schwartz LH, D'Angelica M. The use of imaging in the diagnosis and staging of hepatobiliary malignancies. Surg Oncol Clin N Am. 2007;16:343-368. [PMID: 17560517 DOI: 10.1016/j.soc.2007.04.001] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
16 Cho ES, Park MS, Yu JS, Kim MJ, Kim KW. Biliary ductal involvement of hilar cholangiocarcinoma: multidetector computed tomography versus magnetic resonance cholangiography. J Comput Assist Tomogr 2007;31:72-8. [PMID: 17259836 DOI: 10.1097/01.rct.0000230013.24091.8e] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
17 Kim M, Choi J, Chung YE. Evaluation of Biliary Malignancies Using Multidetector-Row Computed Tomography: . Journal of Computer Assisted Tomography 2010;34:496-505. [DOI: 10.1097/rct.0b013e3181d34532] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
18 Engelbrecht MR, Katz SS, van Gulik TM, Laméris JS, van Delden OM. Imaging of Perihilar Cholangiocarcinoma. American Journal of Roentgenology 2015;204:782-91. [DOI: 10.2214/ajr.14.12830] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
19 Ringe KI, Ringe BP, Bektas H, Opherk JP, Reichelt A, Lotz J, Wacker F, Meyer BC. Characterization and staging of central bile duct stenosis—Evaluation of the hepatocyte specific contrast agent gadoxetate disodium. European Journal of Radiology 2012;81:3028-34. [DOI: 10.1016/j.ejrad.2012.03.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Oliveira IS, Kilcoyne A, Everett JM, Mino-Kenudson M, Harisinghani MG, Ganesan K. Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management. Abdom Radiol (NY). 2017;42:1637-1649. [PMID: 28271275 DOI: 10.1007/s00261-017-1094-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
21 Olthof SC, Othman A, Clasen S, Schraml C, Nikolaou K, Bongers M. Imaging of Cholangiocarcinoma. Visc Med. 2016;32:402-410. [PMID: 28229074 DOI: 10.1159/000453009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
22 Yoo J, Lee JM, Yoon JH, Joo I, Lee DH. Additional Value of Integrated 18F-FDG PET/MRI for Evaluating Biliary Tract Cancer: Comparison with Contrast-Enhanced CT. Korean J Radiol 2021;22:714-24. [PMID: 33660461 DOI: 10.3348/kjr.2020.0689] [Reference Citation Analysis]
23 Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg. 2013;257:191-204. [PMID: 23013805 DOI: 10.1097/sla.0b013e31826f4b0e] [Cited by in Crossref: 107] [Cited by in F6Publishing: 46] [Article Influence: 13.4] [Reference Citation Analysis]
24 Promsorn J, Soontrapa W, Somsap K, Chamadol N, Limpawattana P, Harisinghani M. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma. Abdom Radiol (NY). 2019;44:473-481. [PMID: 30151713 DOI: 10.1007/s00261-018-1742-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
25 Wiggers JK, Groot Koerkamp B, van Klaveren D, Coelen RJ, Nio CY, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Gulik TM, Jarnagin WR. Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging. J Am Coll Surg. 2018;227:238-246.e2. [PMID: 29627334 DOI: 10.1016/j.jamcollsurg.2018.03.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
26 Hennedige TP, Neo WT, Venkatesh SK. Imaging of malignancies of the biliary tract- an update. Cancer Imaging 2014;14:14. [PMID: 25608662 DOI: 10.1186/1470-7330-14-14] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
27 Kobayashi S, Nagano H, Marubashi S, Wada H, Eguchi H, Takeda Y, Tanemura M, Kim T, Doki Y, Mori M. Multidetector computed tomography for preoperative prediction of postsurgical prognosis of patients with extrahepatic biliary cancer: MDCT in Biliary Cancer. J Surg Oncol 2010;101:376-83. [DOI: 10.1002/jso.21501] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
28 Masselli G, Gualdi G. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging. 2008;33:444-451. [PMID: 17638040 DOI: 10.1007/s00261-007-9281-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
29 Doherty B, Nambudiri VE, Palmer WC. Update on the Diagnosis and Treatment of Cholangiocarcinoma. Curr Gastroenterol Rep. 2017;19:2. [PMID: 28110453 DOI: 10.1007/s11894-017-0542-4] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 17.5] [Reference Citation Analysis]
30 Singh A, Gelrud A, Agarwal B. Biliary strictures: diagnostic considerations and approach. Gastroenterol Rep (Oxf). 2015;3:22-31. [PMID: 25355800 DOI: 10.1093/gastro/gou072] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 10.4] [Reference Citation Analysis]
31 Esnaola NF, Meyer JE, Karachristos A, Maranki JL, Camp ER, Denlinger CS. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016;122:1349-1369. [PMID: 26799932 DOI: 10.1002/cncr.29692] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 19.4] [Reference Citation Analysis]
32 Malikowski T, Levy MJ, Gleeson FC, Storm AC, Vargas EJ, Topazian MD, Abu Dayyeh BK, Iyer PG, Rajan E, Gores GJ, Roberts LR, Chandrasekhara V. Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With Cholangiocarcinoma. Hepatology. 2020;72:940-948. [PMID: 31860935 DOI: 10.1002/hep.31077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
33 Ayuso J, Pagés M, Darnell A. Imaging bile duct tumors: staging. Abdom Imaging 2013;38:1071-81. [DOI: 10.1007/s00261-013-0021-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
34 Serrablo A, Tejedor L. Outcome of surgical resection in Klatskin tumors. World J Gastrointest Oncol 2013; 5(7): 147-158 [PMID: 23919109 DOI: 10.4251/wjgo.v5.i7.147] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
35 Chung SH, Lee MS, Kim KS, Kim SI, Won JY, Lee DY, Lee KH. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients. Cardiovasc Intervent Radiol 2011;34:1236-43. [PMID: 21290126 DOI: 10.1007/s00270-010-0079-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhou Q, Guan Y, Mao L, Zhu Y, Chen J, Shi J, Tang M, Qiu Y, Zhu B, He J. Modification and establishment of CT criteria in preoperative assessment of portal venous invasion by hilar cholangiocarcinoma. HPB 2018;20:1163-71. [DOI: 10.1016/j.hpb.2018.05.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Gore RM, Shelhamer RP. Biliary tract neoplasms: diagnosis and staging. Cancer Imaging 2007;7 Spec No A:S15-23. [PMID: 17921093 DOI: 10.1102/1470-7330.2007.9016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
38 Chen FM, Ni JM, Zhang ZY, Zhang L, Li B, Jiang CJ. Presurgical Evaluation of Pancreatic Cancer: A Comprehensive Imaging Comparison of CT Versus MRI. AJR Am J Roentgenol. 2016;206:526-535. [PMID: 26901008 DOI: 10.2214/ajr.15.15236] [Cited by in Crossref: 46] [Cited by in F6Publishing: 13] [Article Influence: 9.2] [Reference Citation Analysis]
39 Vilgrain V. Staging cholangiocarcinoma by imaging studies. HPB (Oxford). 2008;10:106-109. [PMID: 18773065 DOI: 10.1080/13651820801992617] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
40 Ito K, Sakamoto Y, Isayama H, Nakai Y, Watadani T, Tanaka M, Ushiku T, Akamatsu N, Kaneko J, Arita J, Hasegawa K, Kokudo N. The Impact of MDCT and Endoscopic Transpapillary Mapping Biopsy to Predict Longitudinal Spread of Extrahepatic Cholangiocarcinoma. J Gastrointest Surg 2018;22:1528-37. [DOI: 10.1007/s11605-018-3793-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
41 Gaspersz MP, Buettner S, van Vugt JLA, Roos E, Coelen RJS, Vugts J, Belt EJ, de Jonge J, Polak WG, Willemssen FEJA, van Gulik TM, IJzermans JNM, Groot Koerkamp B. Conditional survival in patients with unresectable perihilar cholangiocarcinoma. HPB (Oxford) 2017;19:966-71. [PMID: 28754366 DOI: 10.1016/j.hpb.2017.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
42 Ji G, Zhu F, Zhang Y, Liu X, Wu F, Wang K, Xia Y, Zhang Y, Jiang W, Li X, Wang X. A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma. Eur Radiol 2019;29:3725-35. [DOI: 10.1007/s00330-019-06142-7] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
43 Valls C, Ruiz S, Martinez L, Leiva D. Radiological diagnosis and staging of hilar cholangiocarcinoma. World J Gastrointest Oncol 2013; 5(7): 115-126 [PMID: 23919105 DOI: 10.4251/wjgo.v5.i7.115] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
44 Nagino M, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Kondo S, Furuse J, Saito H, Tsuyuguchi T, Yoshikawa T. Preoperative biliary drainage for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:25-30. [PMID: 18274841 DOI: 10.1007/s00534-007-1277-7] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
45 Coelen RJ, Ruys AT, Wiggers JK, Nio CY, Verheij J, Gouma DJ, Besselink MG, Busch OR, van Gulik TM. Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy. Ann Surg Oncol. 2016;23:904-910. [PMID: 27586005 DOI: 10.1245/s10434-016-5531-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
46 Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol. 2012;47:1165-1176. [PMID: 22847554 DOI: 10.1007/s00535-012-0628-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
47 Ji GW, Zhu FP, Wang K, Jiao CY, Shao ZC, Li XC. Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy. J Gastrointest Surg. 2017;21:666-675. [PMID: 28168674 DOI: 10.1007/s11605-017-3377-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
48 Ercolani G, Zanello M, Grazi GL, Cescon M, Ravaioli M, Del Gaudio M, Vetrone G, Cucchetti A, Brandi G, Ramacciato G, Pinna AD. Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center. J Hepatobiliary Pancreat Sci. 2010;17:329-337. [PMID: 20464563 DOI: 10.1007/s00534-009-0249-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
49 Charbel H, Al-Kawas FH. Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep. 2011;13:182-187. [PMID: 21271364 DOI: 10.1007/s11894-011-0178-8] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
50 Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15(34): 4240-4262 [PMID: 19750567 DOI: 10.3748/wjg.15.4240] [Cited by in CrossRef: 175] [Cited by in F6Publishing: 153] [Article Influence: 14.6] [Reference Citation Analysis]
51 Patel T, Singh P. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol. 2007;23:317-323. [PMID: 17414849 DOI: 10.1097/mog.0b013e3280495451] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
52 Ringe KI, Wacker F. Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography. Best Pract Res Clin Gastroenterol. 2015;29:253-265. [PMID: 25966426 DOI: 10.1016/j.bpg.2015.02.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
53 Sergi C, Shen F, Bouma G. Intraepithelial lymphocytes, scores, mimickers and challenges in diagnosing gluten-sensitive enteropathy (celiac disease). World J Gastroenterol 2017; 23(4): 573-589 [PMID: 28216964 DOI: 10.3748/wjg.v23.i4.573] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
54 Larghi A, Tringali A, Lecca PG, Giordano M, Costamagna G. Management of hilar biliary strictures. Am J Gastroenterol. 2008;103:458-473. [PMID: 18028506 DOI: 10.1111/j.1572-0241.2007.01645.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 4.7] [Reference Citation Analysis]
55 Brandi G, Venturi M, Pantaleo MA, Ercolani G;  GICO. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center. Dig Liver Dis. 2016;48:231-241. [PMID: 26769568 DOI: 10.1016/j.dld.2015.11.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
56 Mcnamara MG, Walter T, Horgan AM, Amir E, Cleary S, Mckeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ. Outcome of Adjuvant Therapy in Biliary Tract Cancers. American Journal of Clinical Oncology 2015;38:382-7. [DOI: 10.1097/coc.0b013e31829e19fb] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
57 Ruys AT, Busch OR, Rauws EA, Gouma DJ, van Gulik TM. Prognostic impact of preoperative imaging parameters on resectability of hilar cholangiocarcinoma. HPB Surg 2013;2013:657309. [PMID: 23861556 DOI: 10.1155/2013/657309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
58 Ramos Rubio E. Radicalidad en la cirugía del colangiocarcinoma hiliar (tumor de Klatskin). Cirugía Española 2007;82:11-5. [DOI: 10.1016/s0009-739x(07)71654-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
59 Zhang H, Zhu J, Ke F, Weng M, Wu X, Li M, Quan Z, Liu Y, Zhang Y, Gong W. Radiological Imaging for Assessing the Respectability of Hilar Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Biomed Res Int. 2015;2015:497942. [PMID: 26448940 DOI: 10.1155/2015/497942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
60 Bi L, Liu Y, Xu J, Wang X, Zhang T, Li K, Duan M, Huang C, Meng X, Huang Z. A CT-Based Radiomics Nomogram for Preoperative Prediction of Lymph Node Metastasis in Periampullary Carcinomas. Front Oncol 2021;11:632176. [PMID: 34395237 DOI: 10.3389/fonc.2021.632176] [Reference Citation Analysis]
61 Jikei K, Ebata T, Mizuno T, Kyokane T, Matsubara H, Yokoyama S, Kato K, Suzumura K, Hashimoto M, Kawai S, Nagino M; Nagoya Surgical Oncology Group. Oncologic Reappraisal of Bile Duct Resection for Middle-Third Cholangiocarcinoma. Ann Surg Oncol 2021;28:1990-9. [PMID: 32960392 DOI: 10.1245/s10434-020-09157-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Laghi A, Voena C. CT-based Radiomics for Biliary Tract Cancer: A Possible Solution for Predicting Lymph Node Metastases. Radiology 2019;290:99-100. [DOI: 10.1148/radiol.2018182158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
63 Sommer CM, Schwarzwaelder CB, Stiller W, Schindera ST, Heye T, Stampfl U, Ramsauer S, Bellemann N, Weitz J, Schmidt J, Grenacher L, Kauczor HU, Radeleff BA. Dual-Energy Computed-Tomography Cholangiography in Potential Donors for Living-Related Liver Transplantation: Initial Experience. Investigative Radiology 2010;45:406-12. [DOI: 10.1097/rli.0b013e3181dfdabd] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
64 Park MJ, Kim YK, Lim S, Rhim H, Lee WJ. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation. Radiology. 2014;270:768-776. [PMID: 24475800 DOI: 10.1148/radiol.13130009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
65 Joo I, Lee JM. Imaging bile duct tumors: pathologic concepts, classification, and early tumor detection. Abdom Imaging. 2013;38:1334-1350. [PMID: 23925840 DOI: 10.1007/s00261-013-0027-3] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
66 Ni Q, Wang H, Zhang Y, Qian L, Chi J, Liang X, Chen T, Wang J. MDCT assessment of resectability in hilar cholangiocarcinoma. Abdom Radiol (NY). 2017;42:851-860. [PMID: 27770159 DOI: 10.1007/s00261-016-0943-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
67 Ruys AT, van Beem BE, Engelbrecht MR, Bipat S, Stoker J, Van Gulik TM. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol. 2012;85:1255-1262. [PMID: 22919007 DOI: 10.1259/bjr/88405305] [Cited by in Crossref: 75] [Cited by in F6Publishing: 55] [Article Influence: 8.3] [Reference Citation Analysis]
68 Joo I, Lee JM, Yoon JH. Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges. Radiology 2018;288:7-13. [DOI: 10.1148/radiol.2018171187] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 16.3] [Reference Citation Analysis]
69 Capobianco I, Rolinger J, Nadalin S. Resection for Klatskin tumors: technical complexities and results. Transl Gastroenterol Hepatol. 2018;3:69. [PMID: 30363698 DOI: 10.21037/tgh.2018.09.01] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
70 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512-522. [PMID: 21808282 DOI: 10.1038/nrgastro.2011.131.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Hwang J, Kim YK, Choi D, Rhim H, Lee WJ, Hong SS, Kim HJ, Chang YW. Gadoxetic acid-enhanced MRI for T-staging of gallbladder carcinoma: emphasis on liver invasion. Br J Radiol 2014;87:20130608. [PMID: 24288397 DOI: 10.1259/bjr.20130608] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
72 Tamm EP, Balachandran A, Bhosale P, Szklaruk J. Update on 3D and multiplanar MDCT in the assessment of biliary and pancreatic pathology. Abdom Imaging. 2009;34:64-74. [PMID: 18483805 DOI: 10.1007/s00261-008-9416-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
73 Ghouri YA, Mian I, Blechacz B. Cancer review: Cholangiocarcinoma. J Carcinog. 2015;14:1. [PMID: 25788866 DOI: 10.4103/1477-3163.151940] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 13.8] [Reference Citation Analysis]
74 Kim SY. Preoperative Radiologic Evaluation of Cholangiocarcinoma. Korean J Gastroenterol 2017;69:159-63. [PMID: 28329917 DOI: 10.4166/kjg.2017.69.3.159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
75 Unno M, Okumoto T, Katayose Y, Rikiyama T, Sato A, Motoi F, Oikawa M, Egawa S, Ishibashi T. Preoperative assessment of hilar cholangiocarcinoma by multidetector row computed tomography. J Hepatobiliary Pancreat Surg 2007;14:434-40. [DOI: 10.1007/s00534-006-1191-4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 3.9] [Reference Citation Analysis]
76 Khashab MA, Fockens P, Al-haddad MA. Utility of EUS in patients with indeterminate biliary strictures and suspected extrahepatic cholangiocarcinoma (with videos). Gastrointestinal Endoscopy 2012;76:1024-33. [DOI: 10.1016/j.gie.2012.04.451] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
77 Xie C, Aloreidi K, Patel B, Ridgway T, Thambi-Pillai T, Timmerman G, Khan A, Atiq M. Indeterminate biliary strictures: a simplified approach. Expert Rev Gastroenterol Hepatol. 2018;12:189-199. [PMID: 29034764 DOI: 10.1080/17474124.2018.1391090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
78 Choi YH, Lee JM, Lee JY, Han CJ, Choi JY, Han JK, Choi BI. Biliary Malignancy: Value of Arterial, Pancreatic, and Hepatic Phase Imaging With Multidetector-Row Computed Tomography. Journal of Computer Assisted Tomography 2008;32:362-8. [DOI: 10.1097/rct.0b013e318126c134] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
79 Nam JG, Lee JM, Joo I, Ahn SJ, Park JY, Lee KB, Han JK. Intrahepatic Mass-Forming Cholangiocarcinoma: Relationship Between Computed Tomography Characteristics and Histological Subtypes. J Comput Assist Tomogr 2018;42:340-9. [PMID: 29189405 DOI: 10.1097/RCT.0000000000000695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Singh MK, Facciuto ME. Current management of cholangiocarcinoma. Mt Sinai J Med. 2012;79:232-245. [PMID: 22499494 DOI: 10.1002/msj.21298] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
81 Pradella S, Centi N, La Villa G, Mazza E, Colagrande S. Transient hepatic attenuation difference (THAD) in biliary duct disease. Abdom Imaging 2009;34:626-33. [DOI: 10.1007/s00261-008-9445-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
82 Nishikawa T, Tsuyuguchi T, Sakai Y, Sugiyama H, Kishimoto T, Ohtsuka M, Miyazaki M, Yokosuka O. Preoperative assessment of longitudinal extension of cholangiocarcinoma with peroral video-cholangioscopy: a prospective study. Dig Endosc 2014;26:450-7. [PMID: 23981193 DOI: 10.1111/den.12159] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
83 Park J, Kim MH, Kim KP, Park DH, Moon SH, Song TJ, Eum J, Lee SS, Seo DW, Lee SK. Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study. Gut Liver. 2009;3:298-305. [PMID: 20431764 DOI: 10.5009/gnl.2009.3.4.298] [Cited by in Crossref: 104] [Cited by in F6Publishing: 86] [Article Influence: 8.7] [Reference Citation Analysis]
84 Choi JY, Kim MJ, Lee JM, Kim KW, Lee JY, Han JK, Choi BI. Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography. AJR Am J Roentgenol. 2008;191:1448-1457. [PMID: 18941084 DOI: 10.2214/ajr.07.3992] [Cited by in Crossref: 75] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
85 Buettner S, van Vugt JLA, Gaspersz MP, Coelen RJS, Roos E, Labeur TA, Margonis GA, Ethun CG, Maithel SK, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, IJzermans JNM, van Gulik TM, Pawlik TM, Groot Koerkamp B. Survival after resection of perihilar cholangiocarcinoma in patients with lymph node metastases. HPB (Oxford) 2017;19:735-40. [PMID: 28549744 DOI: 10.1016/j.hpb.2017.04.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
86 Wigham A, Alexander Grant L. Preoperative hepatobiliary imaging: what does the radiologist need to know? Semin Ultrasound CT MR 2013;34:2-17. [PMID: 23395314 DOI: 10.1053/j.sult.2012.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
87 Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011; 2(2): 94-107 [PMID: 21603318 DOI: 10.5306/wjco.v2.i2.94] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
88 Chung YE, Kim MJ, Park YN, Lee YH, Choi JY. Staging of extrahepatic cholangiocarcinoma. Eur Radiol. 2008;18:2182-2195. [PMID: 18458911 DOI: 10.1007/s00330-008-1006-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
89 Songthamwat M, Chamadol N, Khuntikeo N, Thinkhamrop J, Koonmee S, Chaichaya N, Bethony J, Thinkhamrop B. Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand. World J Surg Oncol 2017;15:176. [PMID: 28931405 DOI: 10.1186/s12957-017-1246-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
90 Lee DH, Kim B, Lee ES, Kim HJ, Min JH, Lee JM, Choi MH, Seo N, Choi SH, Kim SH, Lee SS, Park YS, Chung YE; Korean Society of Abdominal Radiology. Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology. Korean J Radiol 2021;22:41-62. [PMID: 32901457 DOI: 10.3348/kjr.2019.0803] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
91 Park HS, Lee JM, Choi JY, Lee MW, Kim HJ, Han JK, Choi BI. Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography. AJR Am J Roentgenol. 2008;190:396-405. [PMID: 18212225 DOI: 10.2214/ajr.07.2310] [Cited by in Crossref: 105] [Cited by in F6Publishing: 26] [Article Influence: 8.1] [Reference Citation Analysis]
92 Ryoo I, Lee JM, Park HS, Han JK, Choi BI. Preoperative assessment of longitudinal extent of bile duct cancers using MDCT with multiplanar reconstruction and minimum intensity projections: Comparison with MR cholangiography. European Journal of Radiology 2012;81:2020-6. [DOI: 10.1016/j.ejrad.2011.06.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
93 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512-522. [PMID: 21808282 DOI: 10.1038/nrgastro.2011.131] [Cited by in Crossref: 348] [Cited by in F6Publishing: 343] [Article Influence: 34.8] [Reference Citation Analysis]
94 Watadani T, Akahane M, Yoshikawa T, Ohtomo K. Preoperative assessment of hilar cholangiocarcinoma using multidetector-row CT: correlation with histopathological findings. Radiat Med 2008;26:402-7. [PMID: 18769997 DOI: 10.1007/s11604-008-0249-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
95 Sun HY, Lee JM, Park HS, Yoon JH, Baek JH, Han JK, Choi BI. Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer. J Magn Reson Imaging. 2013;38:138-147. [PMID: 23281093 DOI: 10.1002/jmri.23957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
96 Jegatheeswaran S, Sheen AJ, Siriwardena AK. Contemporary management of perihilar cholangiocarcinoma in a nontransplant hepatopancreatobiliary center. Eur J Gastroenterol Hepatol 2013;25:1099-104. [PMID: 23466490 DOI: 10.1097/MEG.0b013e32835fba3a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Hu HJ, Jin YW, Zhou RX, Ma WJ, Yang Q, Wang JK, Liu F, Cheng NS, Li FY. Clinical Value of Inflammation-Based Prognostic Scores to Predict the Resectability of Hyperbilirubinemia Patients with Potentially Resectable Hilar Cholangiocarcinoma. J Gastrointest Surg 2019;23:510-7. [PMID: 30076591 DOI: 10.1007/s11605-018-3892-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
98 Wirth TC, Vogel A. Surveillance in cholangiocellular carcinoma. Best Pract Res Clin Gastroenterol. 2016;30:987-999. [PMID: 27938792 DOI: 10.1016/j.bpg.2016.11.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
99 Bhardwaj N, Garcea G, Dennison AR, Maddern GJ. The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World J Surg 2015;39:2748-56. [PMID: 26133907 DOI: 10.1007/s00268-015-3125-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
100 Choi JY, Lee JM, Lee JY, Kim SH, Lee MW, Han JK, Choi BI. Assessment of hilar and extrahepatic bile duct cancer using multidetector CT: value of adding multiplanar reformations to standard axial images. Eur Radiol 2007;17:3130-8. [PMID: 17486346 DOI: 10.1007/s00330-007-0658-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
101 Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist. 2006;11:913-922. [PMID: 16951395 DOI: 10.1634/theoncologist.11-8-913] [Cited by in Crossref: 68] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
102 Mahajan MS, Moorthy S, Karumathil SP, Rajeshkannan R, Pothera R. Hilar cholangiocarcinoma: Cross sectional evaluation of disease spectrum. Indian J Radiol Imaging 2015;25:184-92. [PMID: 25969643 DOI: 10.4103/0971-3026.155871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
103 Holzapfel K, Gaa J, Schubert EC, Eiber M, Kleeff J, Rummeny EJ, Loos M. Value of diffusion-weighted MR imaging in the diagnosis of lymph node metastases in patients with cholangiocarcinoma. Abdom Radiol 2016;41:1937-41. [DOI: 10.1007/s00261-016-0791-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
104 Choi ER, Chung YH, Lee JK, Lee KT, Lee KH, Choi DW, Choi SH, Heo JS, Jang K, Park SM, Lim JH. Preoperative evaluation of the longitudinal extent of borderline resectable hilar cholangiocarcinoma by intraductal ultrasonography: Longitudinal extent of cholangiocarcinoma. Journal of Gastroenterology and Hepatology 2011;26:1804-10. [DOI: 10.1111/j.1440-1746.2011.06804.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
105 Jhaveri KS, Hosseini-Nik H. MRI of cholangiocarcinoma. J Magn Reson Imaging. 2015;42:1165-1179. [PMID: 25447417 DOI: 10.1002/jmri.24810] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]